Analysis D. Western Therapeutics Institute, Inc. (4576)
6/4/2024
Analysis of D. Western Therapeutics Institute, Inc. (4576)
D. Western Therapeutics Institute, Inc. is showing some interesting trends based on the provided data.- The RSI indicator is currently at 78.22, indicating that the stock may be overbought and potentially due for a correction.
- The MACD indicator is negative at -0.71, with the MACD line below the signal line, suggesting a bearish trend.
- The Moving Average (MA) indicator is at 103.12, which is below the current price close of 156.00, indicating a potential uptrend.
- The stock price has been fluctuating recently, with highs around 163.00 and lows around 156.00.
Overall, it seems that D. Western Therapeutics Institute, Inc. may be in a short-term overbought condition, but the moving averages suggest a potential uptrend. Traders and investors should closely monitor the stock for any signs of a reversal or continuation of the current trends.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at this time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock has a beta of 1.264 and has experienced a moderate change in its fifty-two week range.
Valuation metrics show that the company has a relatively high PEG ratio and price-to-book ratio. The stock is trading at a forward PE ratio and has a significant market capitalization.
The stock price summary includes key metrics such as the day 50 and 200 moving averages, as well as the fifty-two week high and low prices.
Lastly, the dividends and splits information shows the company's dividend dates, payout ratio, and historical dividend yields. The company has also undergone a stock split in the past.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite fluctuations in other financial metrics, the gross profit has generally followed the trend of increasing sales revenue.
3. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
4. Net income has also shown an increasing trend, reaching $97 billion in 2023 from $57.4 billion in 2020.
5. The company has been able to manage its operating expenses effectively, as seen in the consistent growth of operating income.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
7. The company has been able to generate positive non-operating interest income, contributing to its overall profitability.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020 and its lowest point in 2022.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on generating positive cash flows from operating activities and making strategic investments and financing decisions.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is higher than the EPS of $1.35 from the same quarter a year ago.
3. For the current year ending on September 30, 2024, the average estimated annual EPS is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. Looking ahead to the next year ending on September 30, 2025, the average estimated annual EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 in the current year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, representing a 2% increase from the same quarter last year. The number of analysts providing estimates is 25.
Looking ahead to the next quarter ending on September 30, 2024, the average estimate is $85,501,800,000, with a sales growth of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average estimate is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates for the annual sales is 38.
In the following fiscal year ending on September 30, 2025, the average estimate is $380,772,000,000, indicating a more significant growth of 6% from the previous year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in both the short term and the long term.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.6% in the current year and 9.7% in the next year.
- For the current quarter and the next quarter, the growth rate is estimated to be around 5.1%.
- Over the next 5 years, the company is projected to have a compound annual growth rate (CAGR) of approximately 9.7%.
- However, when looking at the past 5 years, the company had a higher growth rate of around 20.1% per annum.
Overall, it appears that the company's growth rate is expected to slow down compared to the past 5 years, but it is still projected to grow steadily in the upcoming periods.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions regarding the future price of the security, with the low end at $164, the high end at $275, and the median at $201.43. The current price of the security is $192.25, which is below both the average and median forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
MACD of 4576
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
